Your browser doesn't support javascript.
loading
Correction: Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union.
Alnuhait, Mohammed; Alshammari, Abdullah; Alharbi, Manar; Alotaibi, Lina; Alharbi, Reem; Khobrani, Attiah; Alkhudair, Nora; Alshamrani, Majed; Alrajhi, Abdullah M.
Affiliation
  • Alnuhait M; Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. manuhait@uqu.edu.sa.
  • Alshammari A; Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Alharbi M; Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Alotaibi L; Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Alharbi R; Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Khobrani A; Pharmaceutical Care Services, King Abdullah Medical City, Makkah, Saudi Arabia.
  • Alkhudair N; Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Alshamrani M; Department of Pharmaceutical Care Services, King Abdulaziz Medical City (KAMC), Jeddah, Saudi Arabia.
  • Alrajhi AM; Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia.
Ther Innov Regul Sci ; 58(4): 687-688, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38625647

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ther Innov Regul Sci Year: 2024 Document type: Article Affiliation country: Saudi Arabia Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ther Innov Regul Sci Year: 2024 Document type: Article Affiliation country: Saudi Arabia Country of publication: Switzerland